ARTICLE | Company News
Cengent, Dynamis deal
November 22, 2004 8:00 AM UTC
Cengent will use its Genes to Leads lead identification technology to screen candidates against a target from Dynamis. The target is an enzyme that causes the formation of 3-deoxyglucosone, which is a...